BPIQ Blog

Jun 13, 20223 min read

Biopharma Daily Stock Updates - 06/13/22

$XBI $63.32 | -5.53% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -10.7% Novavax COVID-19...

Jun 13, 20223 min read

Free Biopharma Daily Stock Updates - 06/13/22

$XBI $63.32 | -5.53% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -10.7% Novavax COVID-19...

May 18, 20221 min read

Q1 2022 Baker bros Biotech Hedge Fund Update

At BPIQ we have started to track quarterly 13F filings for some of the largest biotech hedge funds. Q1 2022 13F filings were made on or...

Dec 31, 20212 min read

J.P. Morgan Healthcare Conference

The 40th Annual J.P. Morgan Health Care Conference is taking place fully online from January 10-13, 2022. "This premier conference is...

Apr 8, 201910 min read

Incyte (INCY) appears to have the stronger hand in its patent disputes with Concert (CNCE), regardle

BIopharma companies (Concert and Incyte) patent dispute.

Apr 8, 20197 min read

Incyte (INCY) appears to have the stronger hand in its patent disputes with Concert (CNCE), regardle

(For a longer version of this article, with more detailed legal facts, please CLICK HERE.) Concert (CNCE) and Incyte (INCY) have been...

Jump start your biotech due diligence

Our platform helps you uncover your next biotech investment opportunity